X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse TTK HEALTHCARE with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TTK HEALTHCARE   TEVA PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
TEVA PHARMA
Dec-13
TTK HEALTHCARE/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs6632,674-   
Low Rs3992,323-   
Sales per share (Unadj.) Rs535.61,534.8-  
Earnings per share (Unadj.) Rs15.995.9-  
Cash flow per share (Unadj.) Rs20.0219.9-  
Dividends per share (Unadj.) Rs4.0083.93-  
Dividend yield (eoy) %0.83.4 22.4%  
Book value per share (Unadj.) Rs137.61,704.9-  
Shares outstanding (eoy) m7.77848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.01.6 60.9%   
Avg P/E ratio x33.326.1 127.8%  
P/CF ratio (eoy) x26.511.4 233.5%  
Price / Book Value ratio x3.91.5 263.4%  
Dividend payout %25.187.5 28.7%   
Avg Mkt Cap Rs m4,1272,118,923 0.2%   
No. of employees `0001.744.9 3.8%   
Total wages/salary Rs m6070-   
Avg. sales/employee Rs Th2,436.728,958.0 8.4%   
Avg. wages/employee Rs Th355.20-   
Avg. net profit/employee Rs Th72.51,809.0 4.0%   
INCOME DATA
Net Sales Rs m4,1621,301,518 0.3%  
Other income Rs m610-   
Total revenues Rs m4,2231,301,518 0.3%   
Gross profit Rs m197356,421 0.1%  
Depreciation Rs m32105,203 0.0%   
Interest Rs m3025,564 0.1%   
Profit before tax Rs m197225,655 0.1%   
Minority Interest Rs m01,025 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-148,130 0.0%   
Tax Rs m73-2,755 -2.6%   
Profit after tax Rs m12481,305 0.2%  
Gross profit margin %4.727.4 17.3%  
Effective tax rate %37.0-1.2 -3,031.4%   
Net profit margin %3.06.2 47.7%  
BALANCE SHEET DATA
Current assets Rs m1,629879,040 0.2%   
Current liabilities Rs m1,058766,598 0.1%   
Net working cap to sales %13.78.6 158.8%  
Current ratio x1.51.1 134.3%  
Inventory Days Days3091 32.8%  
Debtors Days Days3496 35.0%  
Net fixed assets Rs m556425,104 0.1%   
Share capital Rs m783,204 2.4%   
"Free" reserves Rs m8780-   
Net worth Rs m1,0691,445,740 0.1%   
Long term debt Rs m159665,495 0.0%   
Total assets Rs m2,3992,974,386 0.1%  
Interest coverage x7.69.8 77.1%   
Debt to equity ratio x0.10.5 32.2%  
Sales to assets ratio x1.70.4 396.4%   
Return on assets %6.43.6 178.4%  
Return on equity %11.65.6 206.0%  
Return on capital %18.54.9 374.2%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Net fx Rs m-300-   
CASH FLOW
From Operations Rs m127207,395 0.1%  
From Investments Rs m-146-73,488 0.2%  
From Financial Activity Rs m22-248,784 -0.0%  
Net Cashflow Rs m3-114,878 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 64.07 Rs / USD

Compare TTK HEALTHCARE With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare TTK HEALTHCARE With: STERLING BIOTECH  NATCO PHARMA  SANOFI INDIA  STRIDES SHASUN LTD  VENUS REMEDIES  



Today's Market

Indian Indices Trade Marginally Higher; Pharma Sector Up 2.4%(11:30 am)

Stock markets in India are presently trading near the dotted line with positive bias. Sectoral indices are trading on a mixed note with stocks in the healthcare sector.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Aug 24, 2017 12:13 PM

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS